Global Myasthenia Gravis (MG) Treatment Market Growth (Status and Outlook) 2025-2031

September 2025 | 100 pages | ID: G531AC3754B7EN
LP Information

Abstracts

According to this study, the global Myasthenia Gravis (MG) Treatment market size will reach US$ 2223 million by 2031.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Myasthenia Gravis (MG) Treatment Industry Forecast” looks at past sales and reviews total world Myasthenia Gravis (MG) Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Myasthenia Gravis (MG) Treatment sales for 2025 through 2031. With Myasthenia Gravis (MG) Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Myasthenia Gravis (MG) Treatment industry.

This Insight Report provides a comprehensive analysis of the global Myasthenia Gravis (MG) Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Myasthenia Gravis (MG) Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Myasthenia Gravis (MG) Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Myasthenia Gravis (MG) Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Myasthenia Gravis (MG) Treatment.

This report presents a comprehensive overview, market shares, and growth opportunities of Myasthenia Gravis (MG) Treatment market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Drug Treatment
• Rapid Immunotherapies
• Others

Segmentation by Application:

• Hospitals and Clinics
• Diagnostic Centers
• Academic and Research Organizations

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Alexion Pharmaceutical
• Grifols
• Avadel Pharmaceuticals
• Novartis
• Pfizer
• AbbVie
• F. Hoffmann-La Roche
• GlaxoSmithKline
• Bausch Health Companies
• Shire

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Myasthenia Gravis (MG) Treatment Market Size (2020-2031)
  2.1.2 Myasthenia Gravis (MG) Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Myasthenia Gravis (MG) Treatment by Country/Region (2020, 2024 & 2031)
2.2 Myasthenia Gravis (MG) Treatment Segment by Type
  2.2.1 Drug Treatment
  2.2.2 Rapid Immunotherapies
  2.2.3 Others
2.3 Myasthenia Gravis (MG) Treatment Market Size by Type
  2.3.1 Myasthenia Gravis (MG) Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Myasthenia Gravis (MG) Treatment Market Size Market Share by Type (2020-2025)
2.4 Myasthenia Gravis (MG) Treatment Segment by Application
  2.4.1 Hospitals and Clinics
  2.4.2 Diagnostic Centers
  2.4.3 Academic and Research Organizations
2.5 Myasthenia Gravis (MG) Treatment Market Size by Application
  2.5.1 Myasthenia Gravis (MG) Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Myasthenia Gravis (MG) Treatment Market Size Market Share by Application (2020-2025)

3 MYASTHENIA GRAVIS (MG) TREATMENT MARKET SIZE BY PLAYER

3.1 Myasthenia Gravis (MG) Treatment Market Size Market Share by Player
  3.1.1 Global Myasthenia Gravis (MG) Treatment Revenue by Player (2020-2025)
  3.1.2 Global Myasthenia Gravis (MG) Treatment Revenue Market Share by Player (2020-2025)
3.2 Global Myasthenia Gravis (MG) Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 MYASTHENIA GRAVIS (MG) TREATMENT BY REGION

4.1 Myasthenia Gravis (MG) Treatment Market Size by Region (2020-2025)
4.2 Global Myasthenia Gravis (MG) Treatment Annual Revenue by Country/Region (2020-2025)
4.3 Americas Myasthenia Gravis (MG) Treatment Market Size Growth (2020-2025)
4.4 APAC Myasthenia Gravis (MG) Treatment Market Size Growth (2020-2025)
4.5 Europe Myasthenia Gravis (MG) Treatment Market Size Growth (2020-2025)
4.6 Middle East & Africa Myasthenia Gravis (MG) Treatment Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Myasthenia Gravis (MG) Treatment Market Size by Country (2020-2025)
5.2 Americas Myasthenia Gravis (MG) Treatment Market Size by Type (2020-2025)
5.3 Americas Myasthenia Gravis (MG) Treatment Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Myasthenia Gravis (MG) Treatment Market Size by Region (2020-2025)
6.2 APAC Myasthenia Gravis (MG) Treatment Market Size by Type (2020-2025)
6.3 APAC Myasthenia Gravis (MG) Treatment Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Myasthenia Gravis (MG) Treatment Market Size by Country (2020-2025)
7.2 Europe Myasthenia Gravis (MG) Treatment Market Size by Type (2020-2025)
7.3 Europe Myasthenia Gravis (MG) Treatment Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Myasthenia Gravis (MG) Treatment by Region (2020-2025)
8.2 Middle East & Africa Myasthenia Gravis (MG) Treatment Market Size by Type (2020-2025)
8.3 Middle East & Africa Myasthenia Gravis (MG) Treatment Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL MYASTHENIA GRAVIS (MG) TREATMENT MARKET FORECAST

10.1 Global Myasthenia Gravis (MG) Treatment Forecast by Region (2026-2031)
  10.1.1 Global Myasthenia Gravis (MG) Treatment Forecast by Region (2026-2031)
  10.1.2 Americas Myasthenia Gravis (MG) Treatment Forecast
  10.1.3 APAC Myasthenia Gravis (MG) Treatment Forecast
  10.1.4 Europe Myasthenia Gravis (MG) Treatment Forecast
  10.1.5 Middle East & Africa Myasthenia Gravis (MG) Treatment Forecast
10.2 Americas Myasthenia Gravis (MG) Treatment Forecast by Country (2026-2031)
  10.2.1 United States Market Myasthenia Gravis (MG) Treatment Forecast
  10.2.2 Canada Market Myasthenia Gravis (MG) Treatment Forecast
  10.2.3 Mexico Market Myasthenia Gravis (MG) Treatment Forecast
  10.2.4 Brazil Market Myasthenia Gravis (MG) Treatment Forecast
10.3 APAC Myasthenia Gravis (MG) Treatment Forecast by Region (2026-2031)
  10.3.1 China Myasthenia Gravis (MG) Treatment Market Forecast
  10.3.2 Japan Market Myasthenia Gravis (MG) Treatment Forecast
  10.3.3 Korea Market Myasthenia Gravis (MG) Treatment Forecast
  10.3.4 Southeast Asia Market Myasthenia Gravis (MG) Treatment Forecast
  10.3.5 India Market Myasthenia Gravis (MG) Treatment Forecast
  10.3.6 Australia Market Myasthenia Gravis (MG) Treatment Forecast
10.4 Europe Myasthenia Gravis (MG) Treatment Forecast by Country (2026-2031)
  10.4.1 Germany Market Myasthenia Gravis (MG) Treatment Forecast
  10.4.2 France Market Myasthenia Gravis (MG) Treatment Forecast
  10.4.3 UK Market Myasthenia Gravis (MG) Treatment Forecast
  10.4.4 Italy Market Myasthenia Gravis (MG) Treatment Forecast
  10.4.5 Russia Market Myasthenia Gravis (MG) Treatment Forecast
10.5 Middle East & Africa Myasthenia Gravis (MG) Treatment Forecast by Region (2026-2031)
  10.5.1 Egypt Market Myasthenia Gravis (MG) Treatment Forecast
  10.5.2 South Africa Market Myasthenia Gravis (MG) Treatment Forecast
  10.5.3 Israel Market Myasthenia Gravis (MG) Treatment Forecast
  10.5.4 Turkey Market Myasthenia Gravis (MG) Treatment Forecast
10.6 Global Myasthenia Gravis (MG) Treatment Forecast by Type (2026-2031)
10.7 Global Myasthenia Gravis (MG) Treatment Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Myasthenia Gravis (MG) Treatment Forecast

11 KEY PLAYERS ANALYSIS

11.1 Alexion Pharmaceutical
  11.1.1 Alexion Pharmaceutical Company Information
  11.1.2 Alexion Pharmaceutical Myasthenia Gravis (MG) Treatment Product Offered
  11.1.3 Alexion Pharmaceutical Myasthenia Gravis (MG) Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Alexion Pharmaceutical Main Business Overview
  11.1.5 Alexion Pharmaceutical Latest Developments
11.2 Grifols
  11.2.1 Grifols Company Information
  11.2.2 Grifols Myasthenia Gravis (MG) Treatment Product Offered
  11.2.3 Grifols Myasthenia Gravis (MG) Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Grifols Main Business Overview
  11.2.5 Grifols Latest Developments
11.3 Avadel Pharmaceuticals
  11.3.1 Avadel Pharmaceuticals Company Information
  11.3.2 Avadel Pharmaceuticals Myasthenia Gravis (MG) Treatment Product Offered
  11.3.3 Avadel Pharmaceuticals Myasthenia Gravis (MG) Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Avadel Pharmaceuticals Main Business Overview
  11.3.5 Avadel Pharmaceuticals Latest Developments
11.4 Novartis
  11.4.1 Novartis Company Information
  11.4.2 Novartis Myasthenia Gravis (MG) Treatment Product Offered
  11.4.3 Novartis Myasthenia Gravis (MG) Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Novartis Main Business Overview
  11.4.5 Novartis Latest Developments
11.5 Pfizer
  11.5.1 Pfizer Company Information
  11.5.2 Pfizer Myasthenia Gravis (MG) Treatment Product Offered
  11.5.3 Pfizer Myasthenia Gravis (MG) Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Pfizer Main Business Overview
  11.5.5 Pfizer Latest Developments
11.6 AbbVie
  11.6.1 AbbVie Company Information
  11.6.2 AbbVie Myasthenia Gravis (MG) Treatment Product Offered
  11.6.3 AbbVie Myasthenia Gravis (MG) Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 AbbVie Main Business Overview
  11.6.5 AbbVie Latest Developments
11.7 F. Hoffmann-La Roche
  11.7.1 F. Hoffmann-La Roche Company Information
  11.7.2 F. Hoffmann-La Roche Myasthenia Gravis (MG) Treatment Product Offered
  11.7.3 F. Hoffmann-La Roche Myasthenia Gravis (MG) Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 F. Hoffmann-La Roche Main Business Overview
  11.7.5 F. Hoffmann-La Roche Latest Developments
11.8 GlaxoSmithKline
  11.8.1 GlaxoSmithKline Company Information
  11.8.2 GlaxoSmithKline Myasthenia Gravis (MG) Treatment Product Offered
  11.8.3 GlaxoSmithKline Myasthenia Gravis (MG) Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 GlaxoSmithKline Main Business Overview
  11.8.5 GlaxoSmithKline Latest Developments
11.9 Bausch Health Companies
  11.9.1 Bausch Health Companies Company Information
  11.9.2 Bausch Health Companies Myasthenia Gravis (MG) Treatment Product Offered
  11.9.3 Bausch Health Companies Myasthenia Gravis (MG) Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Bausch Health Companies Main Business Overview
  11.9.5 Bausch Health Companies Latest Developments
11.10 Shire
  11.10.1 Shire Company Information
  11.10.2 Shire Myasthenia Gravis (MG) Treatment Product Offered
  11.10.3 Shire Myasthenia Gravis (MG) Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 Shire Main Business Overview
  11.10.5 Shire Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Myasthenia Gravis (MG) Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Myasthenia Gravis (MG) Treatment Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Drug Treatment
Table 4. Major Players of Rapid Immunotherapies
Table 5. Major Players of Others
Table 6. Myasthenia Gravis (MG) Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Myasthenia Gravis (MG) Treatment Market Size by Type (2020-2025) & ($ millions)
Table 8. Global Myasthenia Gravis (MG) Treatment Market Size Market Share by Type (2020-2025)
Table 9. Myasthenia Gravis (MG) Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Myasthenia Gravis (MG) Treatment Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Myasthenia Gravis (MG) Treatment Market Size Market Share by Application (2020-2025)
Table 12. Global Myasthenia Gravis (MG) Treatment Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Myasthenia Gravis (MG) Treatment Revenue Market Share by Player (2020-2025)
Table 14. Myasthenia Gravis (MG) Treatment Key Players Head office and Products Offered
Table 15. Myasthenia Gravis (MG) Treatment Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Myasthenia Gravis (MG) Treatment Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Myasthenia Gravis (MG) Treatment Market Size Market Share by Region (2020-2025)
Table 20. Global Myasthenia Gravis (MG) Treatment Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Myasthenia Gravis (MG) Treatment Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Myasthenia Gravis (MG) Treatment Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Myasthenia Gravis (MG) Treatment Market Size Market Share by Country (2020-2025)
Table 24. Americas Myasthenia Gravis (MG) Treatment Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas Myasthenia Gravis (MG) Treatment Market Size Market Share by Type (2020-2025)
Table 26. Americas Myasthenia Gravis (MG) Treatment Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Myasthenia Gravis (MG) Treatment Market Size Market Share by Application (2020-2025)
Table 28. APAC Myasthenia Gravis (MG) Treatment Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Myasthenia Gravis (MG) Treatment Market Size Market Share by Region (2020-2025)
Table 30. APAC Myasthenia Gravis (MG) Treatment Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC Myasthenia Gravis (MG) Treatment Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Myasthenia Gravis (MG) Treatment Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Myasthenia Gravis (MG) Treatment Market Size Market Share by Country (2020-2025)
Table 34. Europe Myasthenia Gravis (MG) Treatment Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe Myasthenia Gravis (MG) Treatment Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Myasthenia Gravis (MG) Treatment Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Myasthenia Gravis (MG) Treatment Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa Myasthenia Gravis (MG) Treatment Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Myasthenia Gravis (MG) Treatment
Table 40. Key Market Challenges & Risks of Myasthenia Gravis (MG) Treatment
Table 41. Key Industry Trends of Myasthenia Gravis (MG) Treatment
Table 42. Global Myasthenia Gravis (MG) Treatment Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global Myasthenia Gravis (MG) Treatment Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global Myasthenia Gravis (MG) Treatment Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global Myasthenia Gravis (MG) Treatment Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. Alexion Pharmaceutical Details, Company Type, Myasthenia Gravis (MG) Treatment Area Served and Its Competitors
Table 47. Alexion Pharmaceutical Myasthenia Gravis (MG) Treatment Product Offered
Table 48. Alexion Pharmaceutical Myasthenia Gravis (MG) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Alexion Pharmaceutical Main Business
Table 50. Alexion Pharmaceutical Latest Developments
Table 51. Grifols Details, Company Type, Myasthenia Gravis (MG) Treatment Area Served and Its Competitors
Table 52. Grifols Myasthenia Gravis (MG) Treatment Product Offered
Table 53. Grifols Myasthenia Gravis (MG) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Grifols Main Business
Table 55. Grifols Latest Developments
Table 56. Avadel Pharmaceuticals Details, Company Type, Myasthenia Gravis (MG) Treatment Area Served and Its Competitors
Table 57. Avadel Pharmaceuticals Myasthenia Gravis (MG) Treatment Product Offered
Table 58. Avadel Pharmaceuticals Myasthenia Gravis (MG) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Avadel Pharmaceuticals Main Business
Table 60. Avadel Pharmaceuticals Latest Developments
Table 61. Novartis Details, Company Type, Myasthenia Gravis (MG) Treatment Area Served and Its Competitors
Table 62. Novartis Myasthenia Gravis (MG) Treatment Product Offered
Table 63. Novartis Myasthenia Gravis (MG) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Novartis Main Business
Table 65. Novartis Latest Developments
Table 66. Pfizer Details, Company Type, Myasthenia Gravis (MG) Treatment Area Served and Its Competitors
Table 67. Pfizer Myasthenia Gravis (MG) Treatment Product Offered
Table 68. Pfizer Myasthenia Gravis (MG) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Pfizer Main Business
Table 70. Pfizer Latest Developments
Table 71. AbbVie Details, Company Type, Myasthenia Gravis (MG) Treatment Area Served and Its Competitors
Table 72. AbbVie Myasthenia Gravis (MG) Treatment Product Offered
Table 73. AbbVie Myasthenia Gravis (MG) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. AbbVie Main Business
Table 75. AbbVie Latest Developments
Table 76. F. Hoffmann-La Roche Details, Company Type, Myasthenia Gravis (MG) Treatment Area Served and Its Competitors
Table 77. F. Hoffmann-La Roche Myasthenia Gravis (MG) Treatment Product Offered
Table 78. F. Hoffmann-La Roche Myasthenia Gravis (MG) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. F. Hoffmann-La Roche Main Business
Table 80. F. Hoffmann-La Roche Latest Developments
Table 81. GlaxoSmithKline Details, Company Type, Myasthenia Gravis (MG) Treatment Area Served and Its Competitors
Table 82. GlaxoSmithKline Myasthenia Gravis (MG) Treatment Product Offered
Table 83. GlaxoSmithKline Myasthenia Gravis (MG) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. GlaxoSmithKline Main Business
Table 85. GlaxoSmithKline Latest Developments
Table 86. Bausch Health Companies Details, Company Type, Myasthenia Gravis (MG) Treatment Area Served and Its Competitors
Table 87. Bausch Health Companies Myasthenia Gravis (MG) Treatment Product Offered
Table 88. Bausch Health Companies Myasthenia Gravis (MG) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. Bausch Health Companies Main Business
Table 90. Bausch Health Companies Latest Developments
Table 91. Shire Details, Company Type, Myasthenia Gravis (MG) Treatment Area Served and Its Competitors
Table 92. Shire Myasthenia Gravis (MG) Treatment Product Offered
Table 93. Shire Myasthenia Gravis (MG) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 94. Shire Main Business
Table 95. Shire Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Myasthenia Gravis (MG) Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Myasthenia Gravis (MG) Treatment Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Myasthenia Gravis (MG) Treatment Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Myasthenia Gravis (MG) Treatment Sales Market Share by Country/Region (2024)
Figure 8. Myasthenia Gravis (MG) Treatment Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Myasthenia Gravis (MG) Treatment Market Size Market Share by Type in 2024
Figure 10. Myasthenia Gravis (MG) Treatment in Hospitals and Clinics
Figure 11. Global Myasthenia Gravis (MG) Treatment Market: Hospitals and Clinics (2020-2025) & ($ millions)
Figure 12. Myasthenia Gravis (MG) Treatment in Diagnostic Centers
Figure 13. Global Myasthenia Gravis (MG) Treatment Market: Diagnostic Centers (2020-2025) & ($ millions)
Figure 14. Myasthenia Gravis (MG) Treatment in Academic and Research Organizations
Figure 15. Global Myasthenia Gravis (MG) Treatment Market: Academic and Research Organizations (2020-2025) & ($ millions)
Figure 16. Global Myasthenia Gravis (MG) Treatment Market Size Market Share by Application in 2024
Figure 17. Global Myasthenia Gravis (MG) Treatment Revenue Market Share by Player in 2024
Figure 18. Global Myasthenia Gravis (MG) Treatment Market Size Market Share by Region (2020-2025)
Figure 19. Americas Myasthenia Gravis (MG) Treatment Market Size 2020-2025 ($ millions)
Figure 20. APAC Myasthenia Gravis (MG) Treatment Market Size 2020-2025 ($ millions)
Figure 21. Europe Myasthenia Gravis (MG) Treatment Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Myasthenia Gravis (MG) Treatment Market Size 2020-2025 ($ millions)
Figure 23. Americas Myasthenia Gravis (MG) Treatment Value Market Share by Country in 2024
Figure 24. United States Myasthenia Gravis (MG) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Myasthenia Gravis (MG) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Myasthenia Gravis (MG) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Myasthenia Gravis (MG) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Myasthenia Gravis (MG) Treatment Market Size Market Share by Region in 2024
Figure 29. APAC Myasthenia Gravis (MG) Treatment Market Size Market Share by Type (2020-2025)
Figure 30. APAC Myasthenia Gravis (MG) Treatment Market Size Market Share by Application (2020-2025)
Figure 31. China Myasthenia Gravis (MG) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Myasthenia Gravis (MG) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Myasthenia Gravis (MG) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Myasthenia Gravis (MG) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 35. India Myasthenia Gravis (MG) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Myasthenia Gravis (MG) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Myasthenia Gravis (MG) Treatment Market Size Market Share by Country in 2024
Figure 38. Europe Myasthenia Gravis (MG) Treatment Market Size Market Share by Type (2020-2025)
Figure 39. Europe Myasthenia Gravis (MG) Treatment Market Size Market Share by Application (2020-2025)
Figure 40. Germany Myasthenia Gravis (MG) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 41. France Myasthenia Gravis (MG) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Myasthenia Gravis (MG) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Myasthenia Gravis (MG) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Myasthenia Gravis (MG) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Myasthenia Gravis (MG) Treatment Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Myasthenia Gravis (MG) Treatment Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Myasthenia Gravis (MG) Treatment Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Myasthenia Gravis (MG) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Myasthenia Gravis (MG) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Myasthenia Gravis (MG) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Myasthenia Gravis (MG) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Myasthenia Gravis (MG) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Myasthenia Gravis (MG) Treatment Market Size 2026-2031 ($ millions)
Figure 54. APAC Myasthenia Gravis (MG) Treatment Market Size 2026-2031 ($ millions)
Figure 55. Europe Myasthenia Gravis (MG) Treatment Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Myasthenia Gravis (MG) Treatment Market Size 2026-2031 ($ millions)
Figure 57. United States Myasthenia Gravis (MG) Treatment Market Size 2026-2031 ($ millions)
Figure 58. Canada Myasthenia Gravis (MG) Treatment Market Size 2026-2031 ($ millions)
Figure 59. Mexico Myasthenia Gravis (MG) Treatment Market Size 2026-2031 ($ millions)
Figure 60. Brazil Myasthenia Gravis (MG) Treatment Market Size 2026-2031 ($ millions)
Figure 61. China Myasthenia Gravis (MG) Treatment Market Size 2026-2031 ($ millions)
Figure 62. Japan Myasthenia Gravis (MG) Treatment Market Size 2026-2031 ($ millions)
Figure 63. Korea Myasthenia Gravis (MG) Treatment Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Myasthenia Gravis (MG) Treatment Market Size 2026-2031 ($ millions)
Figure 65. India Myasthenia Gravis (MG) Treatment Market Size 2026-2031 ($ millions)
Figure 66. Australia Myasthenia Gravis (MG) Treatment Market Size 2026-2031 ($ millions)
Figure 67. Germany Myasthenia Gravis (MG) Treatment Market Size 2026-2031 ($ millions)
Figure 68. France Myasthenia Gravis (MG) Treatment Market Size 2026-2031 ($ millions)
Figure 69. UK Myasthenia Gravis (MG) Treatment Market Size 2026-2031 ($ millions)
Figure 70. Italy Myasthenia Gravis (MG) Treatment Market Size 2026-2031 ($ millions)
Figure 71. Russia Myasthenia Gravis (MG) Treatment Market Size 2026-2031 ($ millions)
Figure 72. Egypt Myasthenia Gravis (MG) Treatment Market Size 2026-2031 ($ millions)
Figure 73. South Africa Myasthenia Gravis (MG) Treatment Market Size 2026-2031 ($ millions)
Figure 74. Israel Myasthenia Gravis (MG) Treatment Market Size 2026-2031 ($ millions)
Figure 75. Turkey Myasthenia Gravis (MG) Treatment Market Size 2026-2031 ($ millions)
Figure 76. Global Myasthenia Gravis (MG) Treatment Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Myasthenia Gravis (MG) Treatment Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Myasthenia Gravis (MG) Treatment Market Size 2026-2031 ($ millions)